The tumor growth curves show that mice receiving RT + G-CSF treatment had a significantly lower growth rate and higher survival rate than other groups until 20 and 40 days after treatment, respectively (Fig. 6a and Supplementary Fig. 35). The gene discussed is CSF3; the disease is neoplasm.